Embryonic stem cell tumor model reveals role of vascular endothelial receptor tyrosine phosphatase in regulating Tie2 pathway in tumor angiogenesis

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 52, 2009, Pages 22399-22404

  Li, Zhe ^a   Huang, Hui ^a   Boland, Patricia ^a   Dominguez, Melissa G ^a   Burfeind, Patricia ^a   Lai, Ka Man ^a   Lin, Hsin Chieh ^a   Gale, Nicholas W ^a   Daly, Christopher ^a   Auerbach, Wojtek ^a   Valenzuela, David ^a   Yancopoulos, George D ^a   Thurston, Gavin ^a  

^a REGENERON PHARMACEUTICALS INC   (United States)

Author keywords

Endothelial cells; Teratoma; VE PTP; VEGF R2

Indexed keywords

ANGIOPOIETIN RECEPTOR; ANTINEOPLASTIC AGENT; PEPTIDE FC FUSION PROTEIN; PROTEIN; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL RECEPTOR TYROSINE PHOSPHATASE; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL TISSUE; ARTERY DIAMETER; ARTICLE; CELL DIFFERENTIATION; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; GENE TARGETING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TERATOMA;

ANGIOPOIETINS; ANIMALS; CELL DIFFERENTIATION; CELL LINE; DISEASE MODELS, ANIMAL; EMBRYONIC STEM CELLS; ENDOTHELIAL CELLS; MICE; MICE, SCID; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 3; TERATOMA; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

MURINAE; MUS;

EID: 76049103879     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0911189106     Document Type: Article

References (33)

1. Ferrara N, Kerbel RS (2005) Angiogenesis as a therapeutic target. Nature 438:967-974.
2. Folkman J (1992) The role of angiogenesis in tumor growth. Semin Cancer Biol 3:65-71.
3. Robertson EJ (1991) Using embryonic stem cells to introduce mutations into the mouse germ line. Biol Reprod 44:238-245.
4. Shalaby F, et al. (1995) Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376:62-66.
5. Ferrara N, et al. (1996) Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380:439-442.
6. Carmeliet P, et al. (1996) Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380:435-439.
7. Gale NW, et al. (2002) Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1. Dev Cell 3:411-423.
8. Suri C, et al. (1996) Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87:1171-1180.
9. Baumer S, et al. (2006) Vascular endothelial cell-specific phosphotyrosine phosphatase (VE-PTP) activity is required for blood vessel development. Blood 107:4754-4762.
10. Dominguez MG, et al. (2007) Vascular endothelial tyrosine phosphatase (VE-PTP)-null mice undergo vasculogenesis but die embryonically because of defects in angiogenesis. Proc Natl Acad Sci USA 104:3243-3248.
11. Rossant J, Papaioannou VE (1984) The relationship between embryonic, embryonal carcinoma and embryo-derived stem cells. Cell Differ 15:155-161.
12. Stewart CL, Vanek M, Wagner EF (1985) Expression of foreign genes from retroviral vectors in mouse teratocarcinoma chimaeras. EMBO J 4:3701-3709.
13. Viloria-Petit A, et al. (2003) Contrasting effects of VEGF gene disruption in embryonic stem cell-derived versus oncogene-induced tumors. EMBO J 22:4091-4102.
14. Shi YP, FerraraN(1999) Oncogenic ras fails to restore an in vivo tumorigenic phenotype in embryonic stem cells lacking vascular endothelial growth factor (VEGF). Biochem Biophys Res Commun 254:480-483.
15. Magnusson PU, et al. (2007) Platelet-derived growth factor receptor-beta constitutive activity promotes angiogenesis in vivo and in vitro. Arterioscler Thromb Vasc Biol 27:2142-2149.
16. Gerecht-Nir S, et al. (2004) Vascular development in early human embryos and in teratomas derived from human embryonic stem cells. Biol Reprod 71:2029-2036.
17. Hardy K, Carthew P, Handyside AH, Hooper ML (1990) Extragonadal teratocarcinoma derived from embryonal stem cells in chimaeric mice. J Pathol 160:71-76.
18. Valenzuela DM, et al. (2003) High-throughput engineering of the mouse genome coupled with high-resolution expression analysis. Nat Biotechnol 21:652-659.
19. Fachinger G, Deutsch U, RisauW(1999) Functional interaction of vascular endothelialprotein-tyrosine phosphatase with the angiopoietin receptor Tie-2. Oncogene 18:5948-5953.
20. Baffert F, et al. (2004) Age-related changes in vascular endothelial growth factor dependency and angiopoietin-1-induced plasticity of adult blood vessels. Circ Res 94:984-992.
21. Thurston G, et al. (1999) Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 286:2511-2514.
22. Thurston G, et al. (2005) Angiopoietin 1 causes vessel enlargement, without angiogenic sprouting, during a critical developmental period. Development 132:3317-3326.
23. Vikkula M, et al. (1996) Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell 87:1181-1190.
24. Davis S, et al. (2003) Angiopoietins have distinct modular domains essential for receptor binding, dimerization and superclustering. Nat Struct Biol 10:38-44.
25. Daly C, et al. (2006) Angiopoietin-2 functions as an autocrine protective factor in stressed endothelial cells. Proc Natl Acad Sci USA 103:15491-15496.
26. Oliner J, et al. (2004) Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2. Cancer Cell 6:507-516.
27. Moore R, Radice GL, Dominis M, Kemler R (1999) The generation and in vivo differentiation of murine embryonal stem cells genetically null for either N-cadherin or Nand P-cadherin. Int J Dev Biol 43:831-834.
28. Martin GR (1981) Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci USA 78:7634-7638.
29. Taverna D, Hynes RO (2001) Reduced blood vessel formation and tumor growth in alpha5-integrin-negative teratocarcinomas and embryoid bodies. Cancer Res 61:5255-5261.
30. Yu J, et al. (2008) Contribution of host-derived tissue factor to tumor neovascularization. Arterioscler Thromb Vasc Biol 28:1975-1981.
31. Winderlich M, et al. (2009) VE-PTP controls blood vessel development by balancing Tie-2 activity. J Cell Biol 185:657-671.
32. Suri C, et al. (1998) Increased vascularization in mice overexpressing angiopoietin-1. Science 282:468-471.
33. Adams NC, Gale NW (2006) Principles and Practice: Mammalian and Avian Transgenesis-New Approaches, eds Pease S, Lois C (Springer, Berlin), pp 131-172.